Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Virtually Flat. More details...
More Biotechs Lay Out Future Plans. More details...
CBT 200 Rises 8 Points. More details...
Including Private and Public Companies. More details...
CBT 200 Off By 36 Points. More details...
CBT 200 Rings Up Sixth Straight Loss. More details...
CBT 200 Drops 35 Points. More details...
CBT 200 Gains More Than 2%. More details...
CBT 200 Sinks 36 Points. More details...
CBT 200 Is Up 9 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
